PET/CT systems will continue to represent the largest segment in the nuclear medicine system market throughout the forecast, primarily due to its significantly higher ASP. In contrast, SPECT scanners represented the smallest segment. SPECT/CT scanners are cannibalizing the SPECT market as they offer increase patient benefits, namely the ability to superimpose a SPECT scan over a CT scan, which allows the physician to obtain more information. Despite the higher rate of growth and larger sales volume, the SPECT/CT segment will not overtake the PET/CT segment in terms of market share throughout the forecast as a result of the high ASP commanded by PET/CT devices.
The U.S. market for nuclear medicine imaging includes positron emission tomography/computed tomography (PET/CT), single photon emission computed tomography (SPECT) and single photon emission computed tomography/computed tomography (SPECT/CT). In 2015, PET/CT systems represented the largest segment of the overall market.
- GE Healthcare
- Siemens Healthcare
- Philips Healthcare
- Toshiba Medical Systems
Others include: Accutome, Agfa Healthcare, Amrad Medical, Analogic, Arcoma-IMIX, Assured Imaging Mobile Mammography, BK Medical, Bracco, C.R. Bard, Canon, Carestream Health, CMR-Naviscan, Cuattro, Del Medical, Digirad, Dilon Technologies, Ellex/Innovative Imaging, Esaote, eZono, Fischer-Giotto, FONAR, Fujifilm, Gamma Medica Inc., Guerbet, Hitachi Medical Systems, iCRco, Imaging Dynamics Company, IMRIS, Konica Minolta, Lakeshore Technologies Inc., Lantheus Medical Imaging, Machnet B.V., Mallinckrodt, MILabs, Mindray, Neusoft Medical Systems, Paradigm, Planmed OY, Quantel Medical, Rayence, Samsung Medison, Shimadzu, SonoCiné, Sonogage, Sonomed Escalon, SonoSite, Spectrum Dynamics Medical, SuperSonic Imagine, SuperSonic Imagine, Swissray, Teleflex, Terason, Tomey, TXR, ViewRay, Zonare, etc.